Home LiteratureArticle Details
PMID: 5539640 Published · ppublish English Journal Article

Production of ultrastructural membrane lesions by the fifth component of complement.

The Journal of experimental medicine ·Vol. 133 ·No. 1 ·1971-01-01 ·Pages 53-62

Polley MJ, Müller-Eberhard HJ, Feldman JD

Abstract

A direct quantitative relationship has been demonstrated between the number of cell bound C4,2 complexes or C5 molecules and the number of ultrastructural lesions visualized on the cell membrane subsequent to immune hemolysis. When bound C4,2 complexes exceeded bound C5 molecules, the number of ultrastructural lesions seen corresponded to the number of C5 molecules. However, in the reverse situation, with bound C5 molecules in excess of bound C4,2 complexes, the latter determined the number of lesions. During the complement-reaction sequence, the lesions first became visible in the nonlytic intermediate complex EAC1,4,2,3,5 and their number was unaffected when lysis was induced by C6-C9. Since the lesions were also demonstrable on the intermediate complex EC5,6,7, it is concluded that the protein C5 is responsible for their production. Once formed, the physical presence of the C5 molecule is no longer required for the manifestation of the lesions as indicated by persistence of lesions after removal of C5 protein by trypsin. The C5-dependent ultra-structural phenomenon has therefore been interpreted to represent a true structural change of the membrane which, however, is not accompanied by a permeability defect.

MeSH Terms
Animals Antigen-Antibody Reactions Binding Sites Cell Membrane/drug effects Complement System Proteins/pharmacology Erythrocytes/immunology Guinea Pigs Hemolysis Humans Microscopy, Electron Sheep Surface Properties
Chemicals
Complement System Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Polley M J
Müller-Eberhard H J
Feldman J D
References (24)
24 references, click to expand
  1. The eighth component of human complement (C8): isolation, characterization, and hemolytic efficiency.
    J Exp Med. 1969 Nov 1;130(5):1145-60 PMID: 5347695
  2. The ninth component of human complement: isolation, description and mode of action.
    Immunology. 1969 Jun;16(6):719-35 PMID: 4182367
  3. A method of trace iodination of proteins for immunologic studies.
    Int Arch Allergy Appl Immunol. 1966;29(2):185-9 PMID: 4160044
  4. ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.
    J Exp Med. 1965 Aug 1;122:277-98 PMID: 14316946
  5. ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.
    J Exp Med. 1963 Sep 1;118:447-66 PMID: 14078003
  6. The reaction mechanism of human C5 in immune hemolysis.
    J Exp Med. 1970 Oct 1;132(4):775-93 PMID: 5508377
  7. Immune lytic transformation: a state of irreversible damage generated as a result of the reaction of the eighth component in the guinea pig complement system.
    J Immunol. 1968 Jan;100(1):46-54 PMID: 4169697
  8. LESIONS IN ERYTHROCYTE MEMBRANES CAUSED BY IMMUNE HAEMOLYSIS.
    Nature. 1964 Apr 18;202:251-2 PMID: 14167777
  9. Interaction of filipin and derivatives with erythrocyte membranes and lipid dispersions: electron microscopic observations.
    Biochim Biophys Acta. 1967;135(5):844-61 PMID: 6065682
  10. Isolation and characterization of two beta1-glycoproteins of human serum.
    J Exp Med. 1960 Feb 1;111:201-15 PMID: 13726744
  11. A comparison of methods for the molecular quantitation of the fourth component of human complement.
    Immunochemistry. 1968 Mar;5(2):155-69 PMID: 4997106
  12. The lesions in cell membranes caused by complement.
    Adv Immunol. 1969;11:75-115 PMID: 4908393
  13. The cytotoxic action of immune gamma globulin and complement on Krebs ascites tumor cells. II. Chemical studies.
    J Exp Med. 1959 May 1;109(5):511-21 PMID: 13641574
  14. Electron microscopic observations on Rous sarcoma virus and cell membranes.
    Nature. 1962 Jun 23;194:1116-9 PMID: 13887581
  15. Enharncement of the hemolytic activity of the second component of human complement by oxidation.
    J Exp Med. 1967 Dec 1;126(6):1013-25 PMID: 4964564
  16. The demonstration in human serum of "conglutinogen-activating factor" and its effect on the third component of complement.
    J Immunol. 1968 Apr;100(4):691-8 PMID: 5645214
  17. Lysis of erythrocytes by complement in the absence of antibody.
    J Exp Med. 1970 Nov;132(5):898-915 PMID: 5470509
  18. Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. 3. The membrane defects caused by complement lysis.
    J Exp Med. 1966 Jun 1;123(6):969-84 PMID: 5941785
  19. STRUCTURE AND ASSEMBLY OF MACROMOLECULAR LIPID COMPLEXES COMPOSED OF GLOBULAR MICELLES.
    J Mol Biol. 1964 May;8:727-48 PMID: 14187398
  20. The cytotoxic action of immune gamma globulin and complement on Krebs ascites tumor cells. I. Ultrastructural studies.
    J Exp Med. 1959 May 1;109(5):505-10 PMID: 13641573
  21. The second component of human complement: its isolation, fragmentation by C'1 esterase, and incorporation into C'3 convertase.
    J Exp Med. 1968 Sep 1;128(3):533-51 PMID: 5666963
  22. NEGATIVE STAINING OF PHOSPHOLIPIDS AND THEIR STRUCTURAL MODIFICATION BY SURFACE-ACTIVE AGENTS AS OBSERVED IN THE ELECTRON MICROSCOPE.
    J Mol Biol. 1964 May;8:660-8 PMID: 14187392
  23. Interactions of the complement system with the surface and endotoxic lipopolysaccharide of Veillonella alcalescens.
    J Exp Med. 1967 May 1;125(5):767-86 PMID: 4164691
  24. Effect of antibody and complement on permeability control in ascites tumor cells and erythrocytes.
    J Exp Med. 1959 Nov 1;110:699-713 PMID: 13851485
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1971-01-01
Pages
53-62
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2138882
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]